Table 1

Demographic and disease-related variables in 163 female patients with systemic lupus erythematosus

Demographic variables

Value


Patient age, years

47 (20 to 82)

Weight, kg

66 (42 to 99)

Height, cm

166 (145 to 182)

Body mass index, kg/m2

24.2 (17.2 to 37.2)

Menopausal status

Premenopausal, n (%)

72 (44)

Disease variables

Disease duration, years

11 (1 to 41)

SLEDAI-2K

5 (0 to 31)

SLICC/ACR Damage Index

2 (0 to 11)

Kidney affection ever by SLE, n (%)

40 (25)

S-creatinine, μmol/L

87 (49 to 291)

Glomerular filtration rate, mL/minute

74 (22 to 172)

Proteinuria, >3.5 g/24 hours, n (%)

9 (6)

End-stage kidney disease, n (%)

1 (0.6)

Hemoglobin, g/L

131 (75 to 158)

Erythrocyte sedimentation rate, mm/hour

25 (2 to 125)

C-reactive protein, mg/L

5 (3 to 100)

Cholesterol, mmol/L

5.4 (2.4 to 9.3)

High-density lipoprotein, mmol/L

1.6 (0.5 to 2.8)

Low-density lipoprotein, mmol/L

3.1 (<0.1 to 6.3)

Triglycerides, mmol/L

1.2 (0.3 to 6.0)

Albumin, g/L

40 (11 to 53)

IgG, g/L

13.5 (5 to 28)

IgA, g/L

2.5 (0.07 to 11)

IgM, g/L

1.0 (0.05 to 4.6)

C3, g/L

0.93 (0.28 to 1.68)

C4, g/L

0.14 (0.02 to 0.28)

Tumor necrosis factor-alpha, pg/mL

2.16 (0.40 to 36.96)

Interleukin-1β, pg/mL

0.47 (0.0 to 9.65)

Interleukin-6, pg/mL

9.67 (2.81 to 119.0)

sIL-6R, ng/mL

48.87 (11.56 to 107.15)

Glucocortocosteroid user, n (%)

85 (52)

Glucocorticosteroid dose, mg

5 (2.5 to 35)

BMD lumbal spine, g/cm2, mean (SD)

1.12 (0.18)

BMD total hip, g/cm2, mean (SD)

0.92 (0.15)

BMD femur neck, g/cm2, mean (SD)

0.89 (0.15)

BMD radius total, g/cm2, mean (SD)

0.50 (0.08)

Number of vertebral fractures per patient

0 (0 to 11)

ICTP, μg/L

3.59 (0.9 to 16.38)

PINP, μg/L

43.0 (9.1 to 177.94)


Values are presented as median (and range) unless indicated otherwise. BMD, bone mineral density; ICTP, C-terminal telopeptide of type I collagen; Ig, immunoglobulin; PINP, N-terminal propeptide of type I procollagen; SD, standard deviation; sIL-6R, soluble interleukin-6 receptor; SLE, systemic lupus erythematosus; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SLICC/ACR, Systemic Lupus International Collaborative Clinics/American College of Rheumatology.

Almehed et al. Arthritis Research & Therapy 2008 10:R15   doi:10.1186/ar2366

Open Data